Adi Dagan

495 total citations
31 papers, 223 citations indexed

About

Adi Dagan is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Surgery. According to data from OpenAlex, Adi Dagan has authored 31 papers receiving a total of 223 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 5 papers in Physiology and 4 papers in Surgery. Recurrent topics in Adi Dagan's work include Cystic Fibrosis Research Advances (14 papers), Neonatal Respiratory Health Research (6 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers). Adi Dagan is often cited by papers focused on Cystic Fibrosis Research Advances (14 papers), Neonatal Respiratory Health Research (6 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers). Adi Dagan collaborates with scholars based in Israel, United States and Belgium. Adi Dagan's co-authors include Ori Efrati, Ifat Sarouk, Daphna Vilozni, Irit Krause, Jyothsna Gattineni, Michel Baum, Deborah T. Blumenthal, Lea Bentur, K. De Boeck and Malena Cohen‐Cymberknoh and has published in prestigious journals such as European Respiratory Journal, Nephrology Dialysis Transplantation and Frontiers in Pharmacology.

In The Last Decade

Adi Dagan

27 papers receiving 219 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adi Dagan Israel 8 113 36 29 26 24 31 223
Meryem Aktöz Türkiye 10 67 0.6× 80 2.2× 32 1.1× 20 0.8× 12 0.5× 39 301
Cristiano de Jesus Correia Brazil 9 37 0.3× 75 2.1× 19 0.7× 8 0.3× 9 0.4× 40 295
Viktoriya Kuntsevich United States 8 57 0.5× 26 0.7× 87 3.0× 27 1.0× 8 0.3× 11 264
Ryuzo Higuchi Japan 10 156 1.4× 45 1.3× 12 0.4× 45 1.7× 53 2.2× 20 318
Kiran Upadhyay United States 9 32 0.3× 42 1.2× 18 0.6× 28 1.1× 28 1.2× 45 274
Sultan Özkurt Türkiye 8 26 0.2× 25 0.7× 15 0.5× 8 0.3× 19 0.8× 37 211
A S Kashyap India 7 22 0.2× 41 1.1× 13 0.4× 40 1.5× 9 0.4× 31 162
Selma El Hassani Morocco 8 27 0.2× 44 1.2× 82 2.8× 9 0.3× 8 0.3× 27 239
Gülay Can Yılmaz Türkiye 10 23 0.2× 50 1.4× 21 0.7× 105 4.0× 26 1.1× 25 225
A F Heeley United Kingdom 10 222 2.0× 46 1.3× 16 0.6× 36 1.4× 33 1.4× 15 317

Countries citing papers authored by Adi Dagan

Since Specialization
Citations

This map shows the geographic impact of Adi Dagan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adi Dagan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adi Dagan more than expected).

Fields of papers citing papers by Adi Dagan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adi Dagan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adi Dagan. The network helps show where Adi Dagan may publish in the future.

Co-authorship network of co-authors of Adi Dagan

This figure shows the co-authorship network connecting the top 25 collaborators of Adi Dagan. A scholar is included among the top collaborators of Adi Dagan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adi Dagan. Adi Dagan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dagan, Adi, et al.. (2025). WS12.01Final height in cystic fibrosis: what are the predictive factors?. Journal of Cystic Fibrosis. 24. S23–S23.
2.
Porges, Robert F., Liana Tripto‐Shkolnik, Noah Gruber, et al.. (2025). Bone Mineral Density and Trabecular Bone Score in Children, Adolescents and Young Adults with Familial Dysautonomia. Calcified Tissue International. 116(1). 88–88.
3.
Reiter, Joel, et al.. (2024). Clinical efficacy of CFTR modulator therapy in people with cystic fibrosis carrying the I1234V mutation. Journal of Cystic Fibrosis. 23(4). 685–689. 4 indexed citations
4.
5.
Abebe‐Campino, Gadi, Hana Golan, Asaf Vivante, et al.. (2023). Insights Image for “Treatment of severe Kaposiform Lymphangiomatosis positive for NRAS mutation by MEK-inhibition”. Pediatric Research. 94(6). 2117–2117. 2 indexed citations
6.
Dagan, Adi, et al.. (2023). P052 Efficacy of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis with normal/near normal FEV1 (≥70%). Journal of Cystic Fibrosis. 22. S79–S79. 1 indexed citations
7.
Abebe‐Campino, Gadi, Hana Golan, Asaf Vivante, et al.. (2022). Treatment of severe Kaposiform lymphangiomatosis positive for NRAS mutation by MEK inhibition. Pediatric Research. 94(6). 1911–1915. 28 indexed citations
8.
Livnat, Galit, Adi Dagan, Einat Shmueli, et al.. (2022). Treatment effects of Elexacaftor/Tezacaftor/Ivacaftor in people with CF carrying non-F508del mutations. Journal of Cystic Fibrosis. 22(3). 450–455. 7 indexed citations
9.
Stolar, Orit, et al.. (2022). Medical cannabis for the treatment of comorbid symptoms in children with autism spectrum disorder: An interim analysis of biochemical safety. Frontiers in Pharmacology. 13. 977484–977484. 7 indexed citations
10.
Reuveny, Ronen, et al.. (2021). The role of inspiratory capacity and tidal flow in diagnosing exercise ventilatory limitation in Cystic Fibrosis. Respiratory Medicine. 192. 106713–106713. 3 indexed citations
11.
Sarouk, Ifat, Hanoch Senderowitz, Malena Cohen‐Cymberknoh, et al.. (2020). Phenotypic and molecular characteristics of CF patients carrying the I1234V mutation. Respiratory Medicine. 170. 106027–106027. 3 indexed citations
12.
Sarouk, Ifat, et al.. (2018). Omalizumab in allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. Journal of Asthma and Allergy. Volume 11. 101–107. 27 indexed citations
13.
Dagan, Adi, Malena Cohen‐Cymberknoh, Michal Shteinberg, et al.. (2017). Ivacaftor for the p.Ser549Arg (S549R) gating mutation – The Israeli experience. Respiratory Medicine. 131. 225–228. 21 indexed citations
14.
Vilozni, Daphna, et al.. (2016). Consequences of Expiratory Flow Limitation at Rest in Subjects with Cystic Fibrosis. Annals of the American Thoracic Society. 13(6). 825–832. 4 indexed citations
15.
Vilozni, Daphna, et al.. (2015). FVC deterioration, airway obstruction determination, and life span in Ataxia telangiectasia. Respiratory Medicine. 109(7). 890–896. 3 indexed citations
16.
17.
Vilozni, Daphna, et al.. (2014). Late-breaking abstract: The Effect of lung volume deterioration on tidal volume, airway flows and life span in ataxia telangiectasia. European Respiratory Journal. 44(Suppl 58). P4518–P4518. 1 indexed citations
18.
Sarouk, Ifat, et al.. (2014). Several siblings with Cystic Fibrosis as a risk factor for poor outcome. Respiratory Medicine. 109(1). 74–78. 5 indexed citations
19.
Dagan, Adi, et al.. (2011). Hypothyroidism in children with steroid-resistant nephrotic syndrome. Nephrology Dialysis Transplantation. 27(6). 2171–2175. 26 indexed citations
20.
Adler, Yehuda, Adi Dagan, Gregory Golovchiner, et al.. (2003). Augmentation of low-frequency ultrasound-induced clot disruption by hydroxyethyl starch is dependent on the duration and intensity of ultrasound exposure; an in vitro study. Ultrasound in Medicine & Biology. 29(3). 483–486. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Meryem Aktöz Breakdown of academic impact, for papers by Cristiano de Jesus Correia Breakdown of academic impact, for papers by Viktoriya Kuntsevich Breakdown of academic impact, for papers by Ryuzo Higuchi Breakdown of academic impact, for papers by Kiran Upadhyay Breakdown of academic impact, for papers by Sultan Özkurt Breakdown of academic impact, for papers by A S Kashyap Breakdown of academic impact, for papers by Selma El Hassani Breakdown of academic impact, for papers by Gülay Can Yılmaz Breakdown of academic impact, for papers by A F Heeley
Rankless by CCL
2026